(Q37032641)

17 August 2017

1 reference

title

Neutrophils in antibody-based immunotherapy of cancer (English)

1 reference

17 August 2017

1 reference

1 reference

1

Marjolein van Egmond

0 references

language of work or name

English

0 references

publication date

1 January 2008

1 reference

Expert Opinion on Biological Therapy

17 August 2017

published in

1 reference

17 August 2017

volume

8

1 reference

17 August 2017

issue

1

1 reference

17 August 2017

page(s)

83-94

1 reference

Tumor antigens as surrogate markers and targets for therapy and vaccines

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Tumor-associated antigens and biomarkers in cancer and immune therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Ligand-targeted therapeutics in anticancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Development trends for monoclonal antibody cancer therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Immunotherapeutic and immunoregulatory drugs in haematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Trastuzumab--mechanism of action and use in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

The mechanism of tumor cell clearance by rituximab in vivo in patients with B-cell chronic lymphocytic leukemia: evidence of caspase activation and apoptosis induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Complement function in mAb-mediated cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Fc receptors are required in passive and active immunity to melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Antibodies, Fc receptors and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

The innate mononuclear phagocyte network depletes B lymphocytes through Fc receptor-dependent mechanisms during anti-CD20 antibody immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

The intriguing role of polymorphonuclear neutrophils in antitumor reactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Neutrophil granulocytes are required for effective Bacillus Calmette-Guérin immunotherapy of bladder cancer and orchestrate local immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Neutrophil-mediated tumor cell cytotoxicity: role of the peroxidase system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Cytotoxicity for tumor cells of cationic proteins from human neutrophil granules

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Mechanism of mammalian cell lysis mediated by peptide defensins. Evidence for an initial alteration of the plasma membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Synergistic cytolysis mediated by hydrogen peroxide combined with peptide defensins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Granzyme B and perforin: constitutive expression in human polymorphonuclear neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Granzyme A: an additional weapon of human polymorphonuclear neutrophils (PMNs) in innate immunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Granzymes A and B are not expressed in human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Human neutrophils lack granzyme A, granzyme B, and perforin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

The neutrophil as a cellular source of chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Phagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide 1/interleukin 8

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

T lymphocyte recruitment by interleukin-8 (IL-8). IL-8-induced degranulation of neutrophils releases potent chemoattractants for human T lymphocytes both in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Expression and regulation of human neutrophil-derived macrophage inflammatory protein 1 alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Neutrophil granulocyte-committed cells can be driven to acquire dendritic cell characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Transdifferentiation of polymorphonuclear neutrophils to dendritic-like cells at the site of inflammation in rheumatoid arthritis: evidence for activation by T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Neutrophils mediate immune modulation of dendritic cells through glycosylation-dependent interactions between Mac-1 and DC-SIGN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Two way communication between neutrophils and dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Monoclonal LYM-1 antibody-dependent cytolysis by human neutrophils exposed to GM-CSF: auto-regulation of target cell attack by cathepsin G.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

FCGR2APolymorphism Is Correlated With Clinical Outcome After Immunotherapy of Neuroblastoma With Anti-GD2 Antibody and Granulocyte Macrophage Colony-Stimulating Factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Treatment of relapsed B-cell non-Hodgkin's lymphoma with a combination of chimeric anti-CD20 monoclonal antibodies (rituximab) and G-CSF: final report on safety and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Phase I study of Rituximab-CHOP regimen in combination with granulocyte colony-stimulating factor in patients with follicular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Immunotherapeutic perspective for bispecific antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Clinical experience with CD64-directed immunotherapy. An overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Antigen targeting to myeloid-specific human Fc gamma RI/CD64 triggers enhanced antibody responses in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Phase I pilot trial of the bispecific antibody MDXH210 (anti-Fc gamma RI X anti-HER-2/neu) in patients whose prostate cancer overexpresses HER-2/neu

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

A phase II study of the bispecific antibody MDX-H210 (anti-HER2 x CD64) with GM-CSF in HER2+ advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

G-CSF-stimulated PMN in immunotherapy of breast cancer with a bispecific antibody to Fc gamma RI and to HER-2/neu (MDX-210).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Phase I clinical trial of the bispecific antibody MDX-H210 (anti-FcgammaRI x anti-HER-2/neu) in combination with Filgrastim (G-CSF) for treatment of advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Immature neutrophils mediate tumor cell killing via IgA but not IgG Fc receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Unique monoclonal antibodies define expression of Fc gamma RI on macrophages and mast cell lines and demonstrate heterogeneity among subcutaneous and other dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Cellular distribution, regulation, and biochemical nature of an Fc alpha receptor in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Receptors for IgA on phagocytic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

FcalphaRI-positive liver Kupffer cells: reappraisal of the function of immunoglobulin A in immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

IgA and the IgA Fc receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Chimeric IgA antibodies against HLA class II effectively trigger lymphoma cell killing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

IgA antibodies for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Triggering Fc alpha-receptor I (CD89) recruits neutrophils as effector cells for CD20-directed antibody therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Association of the high-affinity receptor for IgG (Fc gamma RI) with the gamma subunit of the IgE receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Functional Association between the Human Myeloid Immunoglobulin A Fc Receptor (CD89) and FcR [IMAGE] Chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

FcR gamma-chain dependent signaling in immature neutrophils is mediated by FcalphaRI, but not by FcgammaRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Intimate cell conjugate formation and exchange of membrane lipids precede apoptosis induction in target cells during antibody-dependent, granulocyte-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Mac-1 (CD11b/CD18) is essential for Fc receptor-mediated neutrophil cytotoxicity and immunologic synapse formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Polymorphonuclear granulocytes induce antibody-dependent apoptosis in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

C5a-mediated leukotriene B4-amplified neutrophil chemotaxis is essential in tumor immunotherapy facilitated by anti-tumor monoclonal antibody and beta-glucan

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Natural killer cells and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Tumour-educated macrophages promote tumour progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Effector mechanisms of recombinant IgA antibodies against epidermal growth factor receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

Alternative Endocytic Pathway for Immunoglobulin A Fc Receptors (CD89) Depends on the Lack of FcRγ Association and Protects against Degradation of Bound Ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.8.1.83

21 January 2018

Identifiers

DOI

10.1517/14712598.8.1.83

1 reference

17 August 2017

1 reference